Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bryan Schneider, M.D.
Hoosier Cancer Research Network
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama Hematology Oncology Clinic at Medical West
Birmingham, Alabama, United States
- Georgetown University: Lombardi Comprehensive Cancer Center
Washington D.C., District of Columbia, United States
- University of Florida: Shands Cancer Center
Gainesville, Florida, United States
- Memorial Cancer Institute
Hollywood, Florida, United States
- University of Miami, Sylvester Comprehensive Cancer Center
Miami, Florida, United States
- Memorial Breast Cancer Center: Memorial West
Pembroke Pines, Florida, United States
- Emory University: Winship Cancer Institute
Atlanta, Georgia, United States
- University of Chicago Medicine
Chicago, Illinois, United States
- Community Hospital of Anderson and Madison County, Inc
Anderson, Indiana, United States
- Fort Wayne Oncology & Hematology, Inc.
Fort Wayne, Indiana, United States
- Iu Health Goshen Hospital
Goshen, Indiana, United States
- Community Regional Cancer Center
Indianapolis, Indiana, United States
- Indiana University Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
- St. Vincent Hospital
Indianapolis, Indiana, United States
- Iu Health Arnett Cancer Center
Lafayette, Indiana, United States
- Community Healthcare System: Monroe Medical Associates
Munster, Indiana, United States
- Northern Indiana Cancer Research Consortium
South Bend, Indiana, United States
- Meritus Center for Clinical Research
Hagerstown, Maryland, United States
- Tufts Medical Center
Boston, Massachusetts, United States
- Washington University: Siteman Cancer Center
St Louis, Missouri, United States
- Nebraska Cancer Specialists
Omaha, Nebraska, United States
- University of Cincinnati Cancer Institute
Cincinnati, Ohio, United States
- Mercy Clinic Oncology & Hematology: Mcauley
Oklahoma City, Oklahoma, United States
- Pinnacle Health Cancer Center
Harrisburg, Pennsylvania, United States
- Erlanger Health System
Chattanooga, Tennessee, United States
- Joe Arrington Cancer Research and Treatment Center
Lubbock, Texas, United States
- Virginia Oncology Associates
Norfolk, Virginia, United States
- Froedtert/medical College of Wisconsin
Milwaukee, Wisconsin, United States
- Aurora Health Care
Wauwatosa, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Apr 2014
- Primary completion
- 21 Feb 2021
- Completion
- 9 Sept 2022
- Last update posted
- 28 Sept 2023
- Registered enrollment
- 193
- Registry id
- NCT02101385
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.